Nav: Home

UTSA researchers explore little-known, deadly fungal infections

April 10, 2018

A new study by Althea Campuzano, Ph.D. a student at The University of Texas at San Antonio, and Floyd Wormley, Jr., Professor of Biology and Senior Associate Dean for Research and Graduate Studies, sheds light on little-known fungal infections caused by the fungus Cryptococcus. There are currently no vaccines available for any fungal infection, which can be extremely deadly to patients under treatment for diseases like HIV, AIDS and cancer. Campuzano and Wormley suggest that more research is needed to develop an effective solution to these infections.

"Cryptococcus is a type of fungus that all humans are frequently exposed to without much effect," Campuzano said. "People with healthy immune systems might be infected but may feel no symptoms. It is often cleared or kept in check without people even knowing they've encountered it."

However, a person whose immune system is weakened by illness could face serious complications from being infected by Cryptococcus because the immune system is less able to respond appropriately to the infection when it's weakened. As a result, the body's innate cells, which normally destroy pathogens, allow the fungal infection to spread to the brain, which can lead to meningitis.

"Most people who are infected with fungal meningitis find they have a stiff neck or a headache. The danger is that if it's left untreated, they could be dead within weeks," Wormley said.

People undergoing treatments that could weaken their immune systems are most susceptible to fungal infections. Patients about to undergo organ transplants, for example, take medication to suppress their immune systems to keep their bodies from rejecting the new organ. AIDS, HIV and cancer patients also experience weakened immunity as a result of the illness or their treatments.

"People who have HIV or AIDS often have to be on anti-fungal treatments for the rest of their lives," Wormley said. "That long treatment can lead to the development of fungi that are resistant to the anti-fungal therapy. Also, it's a very trying thing to treat for a long period of time."

In their study, Wormley and Campuzano highlight all current knowledge of the receptors on innate cells, which are responsible for recognizing fungal pathogens and present an argument for more research in the effort of a vaccine or immunotherapy treatment for Cryptococcus.

"One of the biggest challenges we're facing is that no vaccine currently exists for any fungal infection," Campuzano said. "It's not for lack of trying, but part of the problem is that the immune system has such a hard time distinguishing between a human cell and a fungal cell."

Campuzano is working toward that goal by taking a closer look at CARD9, a protein that regulates receptors on innate cells. She and Wormley are interested in how CARD9 regulates the ability of the body to recognize fungi and whether they could manipulate it to trigger an immune response.

"We need more research involved with fungal pathogens in general," she said. "We're advocating for it so that we can work on a vaccine. A lot of people know about the dangers in bacteria and viruses, but this just isn't on their radar at all. We're going to change that."
-end-
UTSA is ranked among the top four universities in the nation under 50 years old, according to Times Higher Education.

University of Texas at San Antonio

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)

The Cancer-Fighting Kitchen, Second Edition: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
by Rebecca Katz (Author), Mat Edelson (Author)

Anticancer: A New Way of Life
by David Servan-Schreiber MD PhD (Author)

The Truth about Cancer: What You Need to Know about Cancer's History, Treatment, and Prevention
by Ty M. Bollinger (Author)

F*ck Cancer: A totally inappropriate self-affirming adult coloring book (Totally Inappropriate Series) (Volume 4)
by Jen Meyers (Author)

Radical Remission: Surviving Cancer Against All Odds
by Kelly A. Turner PhD (Author)

The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies
by Dr. Nasha Winters ND FABNO L.Ac Dipl.OM (Author), Jess Higgins Kelley MNT (Author), Kelly Turner (Foreword)

Tripping over the Truth: How the Metabolic Theory of Cancer Is Overturning One of Medicine's Most Entrenched Paradigms
by Travis Christofferson (Author), Dominic D'Agostino (Foreword)

Cancer Hates Tea: A Unique Preventive and Transformative Lifestyle Change to Help Crush Cancer
by Maria Uspenski (Author), Dr. Mary L. Hardy (Foreword)

Living with Cancer: A Step-by-Step Guide for Coping Medically and Emotionally with a Serious Diagnosis (A Johns Hopkins Press Health Book)
by Vicki A. Jackson (Author), David P. Ryan (Author), Michelle D. Seaton (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Story Behind The Numbers
Is life today better than ever before? Does the data bear that out? This hour, TED speakers explore the stories we tell with numbers — and whether those stories portray the full picture. Guests include psychologist Steven Pinker, economists Tyler Cowen and Michael Green, journalist Hanna Rosin, and environmental activist Paul Gilding.
Now Playing: Science for the People

#487 Knitting in PEARL
This week we're discussing math and things made from yarn. We welcome mathematician Daina Taimina to the show to discuss her book "Crocheting Adventures with Hyperbolic Planes: Tactile Mathematics, Art and Craft for all to Explore", and how making geometric models that people can play with helps teach math. And we speak with research scientist Janelle Shane about her hobby of training neural networks to do things like name colours, come up with Halloween costume ideas, and generate knitting patterns: often with hilarious results. Related links: Crocheting the Hyperbolic Plane by Daina Taimina and David Henderson Daina's Hyperbolic Crochet blog...